Sundrug Co Ltd
TSE:9989
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 440
4 890
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sundrug Co Ltd
Sundrug Co Ltd
Accounts Receivables
Sundrug Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sundrug Co Ltd
TSE:9989
|
Accounts Receivables
¥25.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Accounts Receivables
¥50.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Accounts Receivables
¥80.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
23%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Accounts Receivables
¥51.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Accounts Receivables
¥59.9B
|
CAGR 3-Years
34%
|
CAGR 5-Years
22%
|
CAGR 10-Years
18%
|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Accounts Receivables
¥658m
|
CAGR 3-Years
101%
|
CAGR 5-Years
22%
|
CAGR 10-Years
44%
|
|
Sundrug Co Ltd
Glance View
Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 5,634 full-time employees. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.
See Also
What is Sundrug Co Ltd's Accounts Receivables?
Accounts Receivables
25.9B
JPY
Based on the financial report for Jun 30, 2024, Sundrug Co Ltd's Accounts Receivables amounts to 25.9B JPY.
What is Sundrug Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
14%
Over the last year, the Accounts Receivables growth was 16%. The average annual Accounts Receivables growth rates for Sundrug Co Ltd have been 12% over the past three years , 19% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
